Dehar N, Jabs D, Hopman W, Mates M
Curr Oncol. 2024; 31(7):3939-3948.
PMID: 39057163
PMC: 11276166.
DOI: 10.3390/curroncol31070291.
Lester S, Kaur A, Vegunta S
Oncologist. 2022; 27(7):548-554.
PMID: 35536728
PMC: 9256023.
DOI: 10.1093/oncolo/oyac084.
Moloney B, McAnena P, Ryan E, Beirn E, Waldron R, Connell A
Breast Cancer (Auckl). 2020; 14:1178223420948477.
PMID: 32863709
PMC: 7430084.
DOI: 10.1177/1178223420948477.
Proenca R, Fernandes J, Burnier M, Proenca R
BMJ Case Rep. 2018; 2018.
PMID: 29643136
PMC: 5898278.
DOI: 10.1136/bcr-2017-223542.
Narod S, Sopik V
Breast Cancer Res Treat. 2018; 169(1):9-23.
PMID: 29353366
PMC: 5882625.
DOI: 10.1007/s10549-017-4644-3.
Factors Affecting Concordance between Radiological and Histological Findings in Invasive Lobular Carcinoma - Experience from a National Cancer Centre.
Abu-Sinn D, ODriscoll D, Murphy M
Breast Care (Basel). 2017; 12(2):87-91.
PMID: 28559764
PMC: 5447166.
DOI: 10.1159/000455066.
A Case of a Concurrent and Co-Located Invasive Carcinoma and a Fibroadenoma to Illustrate the Potential of Dual-Energy, Contrast-Enhanced Digital Mammography on the Diagnosis of Complex Breast Lesions.
Travieso Aja M, Munoz P, Rodriguez Rodriguez M, Benitez V, Luzardo O
Iran J Radiol. 2016; 13(3):e32190.
PMID: 27853496
PMC: 5107243.
DOI: 10.5812/iranjradiol.32190.
The use of ultrasonography and digital mammography in women under 40 years with symptomatic breast cancer: a 7-year Irish experience.
Redmond C, Healy G, Murphy C, ODoherty A, Foster A
Ir J Med Sci. 2016; 186(1):63-67.
PMID: 27271165
DOI: 10.1007/s11845-016-1472-0.
Evolving concepts in breast lobular neoplasia and invasive lobular carcinoma, and their impact on imaging methods.
Oliveira T, Elias Jr J, Melo A, Teixeira S, Filho S, Goncalves L
Insights Imaging. 2014; 5(2):183-94.
PMID: 24633840
PMC: 3999371.
DOI: 10.1007/s13244-014-0324-6.
Role of Breast Ultrasound for the Detection and Differentiation of Breast Lesions.
Madjar H
Breast Care (Basel). 2010; 5(2):109-114.
PMID: 20847824
PMC: 2931046.
DOI: 10.1159/000297775.
Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis--analysis of 102,577 diagnostic procedures.
Schaefer F, Waldmann A, Katalinic A, Wefelnberg C, Heller M, Jonat W
Eur Radiol. 2009; 20(5):1085-92.
PMID: 19890643
DOI: 10.1007/s00330-009-1641-x.
MRI patterns of invasive lobular cancer: T1 and T2 features.
Levrini G, Mori C, Vacondio R, Borasi G, Nicoli F
Radiol Med. 2008; 113(8):1110-25.
PMID: 18800196
DOI: 10.1007/s11547-008-0308-z.
Breast scintigraphy today: indications and limitations.
Schillaci O, Buscombe J
Eur J Nucl Med Mol Imaging. 2004; 31 Suppl 1:S35-45.
PMID: 15103505
DOI: 10.1007/s00259-004-1525-x.
Preoperative breast MRI in patients with invasive lobular breast cancer.
Schelfout K, Van Goethem M, Kersschot E, Verslegers I, Biltjes I, Leyman P
Eur Radiol. 2004; 14(7):1209-16.
PMID: 15024602
DOI: 10.1007/s00330-004-2275-7.
Clinical practice. Mammographic screening for breast cancer.
Fletcher S, Elmore J
N Engl J Med. 2003; 348(17):1672-80.
PMID: 12711743
PMC: 3157308.
DOI: 10.1056/NEJMcp021804.
Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
van Gils C, Otten J, Verbeek A, Hendriks J, Holland R
J Epidemiol Community Health. 1998; 52(4):267-71.
PMID: 9616416
PMC: 1756693.
DOI: 10.1136/jech.52.4.267.
The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses.
Kao C, Wang S, Liu T
Eur J Nucl Med. 1994; 21(5):432-6.
PMID: 8062849
DOI: 10.1007/BF00171419.
Tumor biology of infiltrating lobular carcinoma. Implications for management.
Yeatman T, Cantor A, Smith T, Smith S, Reintgen D, Miller M
Ann Surg. 1995; 222(4):549-59; discussion 559-61.
PMID: 7574934
PMC: 1234890.
DOI: 10.1097/00000658-199522240-00012.
Stereotaxic needle localization and cytological diagnosis of occult breast lesions.
Gent H, SPRENGER E, Dowlatshahi K
Ann Surg. 1986; 204(5):580-4.
PMID: 3532974
PMC: 1251343.
DOI: 10.1097/00000658-198611000-00012.
Assessment of malignancy potential in so-called interval mammary carcinomas.
Von Rosen A, Erhardt K, Hellstrom L, Somell A, Auer G
Breast Cancer Res Treat. 1985; 6(3):221-7.
PMID: 3004621
DOI: 10.1007/BF01806772.